Senolytic therapies may not be a regular term to the public. The agents have been under study for many years by scientists who are keen on transforming them as a remedy too many diseases related to aging. Most specialists indicate that we few more years to discover how to handle the aging process using the agents without causing harm to the people using them.

According to several publications, moist work was done by experts looking for ways of using senolytic to improve the physical function of an aging human being. Some reports indicate two types of senolytic drugs the Dasatinib and Quercetin that are taken in combination to prevent cell damage, delay physical dysfunction, and improve lifespan naturally.

In as much Dasatinib is primarily for chemotherapies used in the USA to treat leukemia, Quercetin is a natural flavonoid found in fruits, some beverages, and vegetables. Some leading supplements may be selling ingredients with senolytic properties stating that to convince their potential clients.

Senolytic compounds are those that destroy senescent cells, which are the root causes of aging, and studies are ongoing to confirm the effectiveness of these compounds. That is why some are showing evidence that when Dasatinib and Quercetin are given in combination, you can notice the reduced number of senescent cells than if Dasatinib was used alone. Some senolytic therapies that address age-related ailments are available in pharmacies after the researchers started making progress into ways of selectively killing senescent cells to reduce the aging process and related diseases.

Cells also become senescent in the event of an injury, toxic cell environment, or damage to the DNA cells may be due to cancer. To heal such bad cells a quick way to deal with them is through rapid destruction. Unfortunately, some of these cells may evade this destruction and linger to cause more problems. The lingering senescent cells produce a lethal mix of molecules that cause the inflammation of the body, changes the behavior of nearby cells, and damaging the surrounding tissue structures. As the number of these senescent cells increases, the damage caused to the body also becomes worse.

Fortunately, work on senolytic therapies that can selectively destroy these cells has been handed over from the lab environment to startup companies for improvement. Meanwhile, scientists are still addressing the aftermath caused by senescent cells in the human body while the same efforts are directed at getting a potential cure for most of these damages.

In a separate study, researchers found out that stress called cellular senescence is linked to a toxic tau protein tangles that are the causes most of the brain injuries, Alzheimer’s disease, and other brain diseases. The study noted the presence of senescent cells in the brain of dead a mouse. This experiment also indicates that such ailments can pass through inheritance- this process is called supranuclear palsy.

Effective senolytic therapies would most likely be undertaken at least once in say two or three years to control the number of senescent cells to low and reduce the chance of having degenerative aging-related illnesses.